Anti-TNF vs immunomodulators in indeterminate colitis

What is known

• Indeterminate colitis is usually treated with standard ulcerative colitis therapies including mesalamine, corticosteroids, azathioprine or mercaptopurine, and biologics; controlled trials are scarce due to diagnostic uncertainty and small numbers. ¹
• A retrospective series of 20 patients with medically refractory indeterminate colitis reported a complete response in 14 (70%) treated with infliximab, but this was uncontrolled and not a one-year remission comparison. ^1,2
• In broader IBD, azathioprine and 6-MP are established for maintaining remission and were more effective than placebo at sustaining remission over one year in [Crohn's disease](https://crohnsology.org (patient sites: crohnz.org)/), but these data are not specific to indeterminate colitis. ^3,4

What is unknown / caveats

• No head-to-head anti-TNF vs immunomodulator trial in indeterminate colitis
• Available IC-specific data are small retrospective/uncontrolled series
• Much cited efficacy data are for CD/UC, not IC specifically
• The excerpts provide no direct comparative or one-year sustained-remission data for anti-TNF versus immunomodulators in indeterminate colitis.

References

1. Tremaine WJ. Is indeterminate colitis determinable?. Curr Gastroenterol Rep. 2012;14(2):162-5. PMID: 22314810.

2. Papadakis KA, Treyzon L, Abreu MT, Fleshner PR, Targan SR, Vasiliauskas EA. Infliximab in the treatment of medically refractory indeterminate colitis. Aliment Pharmacol Ther. 2003;18(7):741-7. PMID: 14510748.

3. Vucelic B. [Therapy of inflammatory bowel disease]. Med Arh. 2002;56(1 Suppl 1):37-45. PMID: 12055723.

4. Willot S, Noble A, Deslandres C. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center. Inflamm Bowel Dis. 2011;17(12):2521-6. PMID: 21337668.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.